RU2486772C2 - Высококалорийные питательные композиции - Google Patents

Высококалорийные питательные композиции Download PDF

Info

Publication number: RU2486772C2
Authority: RU; Russia
Prior art keywords: composition; monophosphate; nucleotides; fatty acids; dry weight
Prior art date: 2007-09-17

Application number

RU2010115277/13A

Other languages

English (en)

Russian (ru)

Other versions

RU2010115277A (ru

Inventor

Мартен Анне ХОИЙЕР

Йоханнес Вильхельмус Кристина СЕЙБЕН

Original Assignee

Н.В. Нютрисиа

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-17

Filing date

2008-09-17

Publication date

2013-07-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39666199&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2486772(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-09-17 Application filed by Н.В. Нютрисиа filed Critical Н.В. Нютрисиа

2011-10-27 Publication of RU2010115277A publication Critical patent/RU2010115277A/ru

2013-07-10 Application granted granted Critical

2013-07-10 Publication of RU2486772C2 publication Critical patent/RU2486772C2/ru

Links

239000000203 mixture Substances 0.000 title claims abstract description 124
235000016709 nutrition Nutrition 0.000 title claims description 14
239000002773 nucleotide Substances 0.000 claims abstract description 31
125000003729 nucleotide group Chemical group 0.000 claims abstract description 30
150000001720 carbohydrates Chemical class 0.000 claims abstract description 25
235000014633 carbohydrates Nutrition 0.000 claims abstract description 25
235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims abstract description 23
235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 12
239000000194 fatty acid Substances 0.000 claims abstract description 12
229930195729 fatty acid Natural products 0.000 claims abstract description 12
150000004665 fatty acids Chemical class 0.000 claims abstract description 12
235000018102 proteins Nutrition 0.000 claims abstract description 12
102000004169 proteins and genes Human genes 0.000 claims abstract description 12
108090000623 proteins and genes Proteins 0.000 claims abstract description 12
235000004252 protein component Nutrition 0.000 claims abstract description 10
238000004519 manufacturing process Methods 0.000 claims abstract description 5
235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 14
150000003271 galactooligosaccharides Chemical class 0.000 claims description 14
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 12
210000001035 gastrointestinal tract Anatomy 0.000 claims description 10
235000021140 nondigestible carbohydrates Nutrition 0.000 claims description 10
229920001542 oligosaccharide Polymers 0.000 claims description 8
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 7
229920001202 Inulin Polymers 0.000 claims description 7
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 7
229940029339 inulin Drugs 0.000 claims description 7
208000037824 growth disorder Diseases 0.000 claims description 6
150000002482 oligosaccharides Chemical class 0.000 claims description 6
244000215068 Acacia senegal Species 0.000 claims description 4
229920000084 Gum arabic Polymers 0.000 claims description 4
239000000205 acacia gum Substances 0.000 claims description 4
235000010489 acacia gum Nutrition 0.000 claims description 4
230000004064 dysfunction Effects 0.000 claims description 4
201000003883 Cystic fibrosis Diseases 0.000 claims description 3
206010028980 Neoplasm Diseases 0.000 claims description 3
206010033799 Paralysis Diseases 0.000 claims description 3
201000011510 cancer Diseases 0.000 claims description 3
208000014674 injury Diseases 0.000 claims description 3
235000013336 milk Nutrition 0.000 claims description 3
239000008267 milk Substances 0.000 claims description 3
210000004080 milk Anatomy 0.000 claims description 3
230000036435 stunted growth Effects 0.000 claims description 3
238000001356 surgical procedure Methods 0.000 claims description 3
230000008733 trauma Effects 0.000 claims description 3
229920002907 Guar gum Polymers 0.000 claims description 2
229920000294 Resistant starch Polymers 0.000 claims description 2
235000010417 guar gum Nutrition 0.000 claims description 2
239000000665 guar gum Substances 0.000 claims description 2
229960002154 guar gum Drugs 0.000 claims description 2
235000021254 resistant starch Nutrition 0.000 claims description 2
239000000523 sample Substances 0.000 claims description 2
YZZVIKDAOTXDEB-UHFFFAOYSA-N 4-(aminomethyl)-3-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1h-imidazole-2-thione Chemical compound NCC1=CNC(=S)N1C1CC2=CC(F)=CC(F)=C2CC1 YZZVIKDAOTXDEB-UHFFFAOYSA-N 0.000 claims 4
GRSZFWQUAKGDAV-KQYNXXCUSA-L IMP(2-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-L 0.000 claims 4
TXXYYOUBDOAQDT-UHFFFAOYSA-N 4-nitro-1-(phenylmethoxymethyl)imidazole Chemical compound C1=NC([N+](=O)[O-])=CN1COCC1=CC=CC=C1 TXXYYOUBDOAQDT-UHFFFAOYSA-N 0.000 claims 3
CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims 2
230000012010 growth Effects 0.000 abstract description 16
230000000694 effects Effects 0.000 abstract description 7
206010053759 Growth retardation Diseases 0.000 abstract description 5
231100000001 growth retardation Toxicity 0.000 abstract description 5
235000013305 food Nutrition 0.000 abstract description 4
239000000126 substance Substances 0.000 abstract 1
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 14
241000894006 Bacteria Species 0.000 description 10
UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 8
GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 8
102000004388 Interleukin-4 Human genes 0.000 description 8
108090000978 Interleukin-4 Proteins 0.000 description 8
229950006790 adenosine phosphate Drugs 0.000 description 8
230000004888 barrier function Effects 0.000 description 8
IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 8
IERHLVCPSMICTF-ZAKLUEHWSA-N cytidine-5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-ZAKLUEHWSA-N 0.000 description 8
230000001965 increasing effect Effects 0.000 description 8
230000007358 intestinal barrier function Effects 0.000 description 8
235000021314 Palmitic acid Nutrition 0.000 description 7
230000000968 intestinal effect Effects 0.000 description 7
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 6
210000005027 intestinal barrier Anatomy 0.000 description 6
150000002632 lipids Chemical class 0.000 description 6
235000015097 nutrients Nutrition 0.000 description 6
230000035764 nutrition Effects 0.000 description 6
239000001814 pectin Substances 0.000 description 6
235000010987 pectin Nutrition 0.000 description 6
229920001277 pectin Polymers 0.000 description 6
230000001404 mediated effect Effects 0.000 description 5
230000035699 permeability Effects 0.000 description 5
230000002265 prevention Effects 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
230000002195 synergetic effect Effects 0.000 description 5
DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
239000002253 acid Substances 0.000 description 4
230000006378 damage Effects 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
210000000936 intestine Anatomy 0.000 description 4
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
230000035800 maturation Effects 0.000 description 4
239000006041 probiotic Substances 0.000 description 4
230000000529 probiotic effect Effects 0.000 description 4
235000018291 probiotics Nutrition 0.000 description 4
DJJCXFVJDGTHFX-ZAKLUEHWSA-N uridine-5'-monophosphate Chemical compound O[C@@H]1[C@@H](O)[C@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-ZAKLUEHWSA-N 0.000 description 4
RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 description 3
LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical group Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
125000002252 acyl group Chemical group 0.000 description 3
230000008901 benefit Effects 0.000 description 3
125000004432 carbon atom Chemical group C* 0.000 description 3
235000020247 cow milk Nutrition 0.000 description 3
239000003925 fat Substances 0.000 description 3
235000019197 fats Nutrition 0.000 description 3
239000000835 fiber Substances 0.000 description 3
230000002496 gastric effect Effects 0.000 description 3
RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 3
210000000987 immune system Anatomy 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
238000000034 method Methods 0.000 description 3
239000002777 nucleoside Substances 0.000 description 3
125000003835 nucleoside group Chemical group 0.000 description 3
238000006116 polymerization reaction Methods 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102000011632 Caseins Human genes 0.000 description 2
108010076119 Caseins Proteins 0.000 description 2
208000017667 Chronic Disease Diseases 0.000 description 2
241000588914 Enterobacter Species 0.000 description 2
241000588748 Klebsiella Species 0.000 description 2
108010011756 Milk Proteins Proteins 0.000 description 2
102000014171 Milk Proteins Human genes 0.000 description 2
208000036364 Normal newborn Diseases 0.000 description 2
241000589516 Pseudomonas Species 0.000 description 2
108091028664 Ribonucleotide Proteins 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
235000008452 baby food Nutrition 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
239000005018 casein Substances 0.000 description 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
235000021240 caseins Nutrition 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
235000005911 diet Nutrition 0.000 description 2
230000037213 diet Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
229940107187 fructooligosaccharide Drugs 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
238000011534 incubation Methods 0.000 description 2
210000002490 intestinal epithelial cell Anatomy 0.000 description 2
239000004310 lactic acid Substances 0.000 description 2
235000014655 lactic acid Nutrition 0.000 description 2
235000006180 nutrition needs Nutrition 0.000 description 2
-1 oligosaccharide oligosaccharides Chemical class 0.000 description 2
235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
235000013406 prebiotics Nutrition 0.000 description 2
239000002336 ribonucleotide Substances 0.000 description 2
125000002652 ribonucleotide group Chemical group 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
208000030090 Acute Disease Diseases 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
206010070545 Bacterial translocation Diseases 0.000 description 1
241000186000 Bifidobacterium Species 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000193403 Clostridium Species 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
229920001353 Dextrin Polymers 0.000 description 1
239000004375 Dextrin Substances 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
108010082495 Dietary Plant Proteins Proteins 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
208000017701 Endocrine disease Diseases 0.000 description 1
241000194033 Enterococcus Species 0.000 description 1
239000001188 FEMA 4487 Substances 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
208000004262 Food Hypersensitivity Diseases 0.000 description 1
229920002670 Fructan Polymers 0.000 description 1
241000233866 Fungi Species 0.000 description 1
208000018522 Gastrointestinal disease Diseases 0.000 description 1
206010017964 Gastrointestinal infection Diseases 0.000 description 1
102000018997 Growth Hormone Human genes 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
108010070551 Meat Proteins Proteins 0.000 description 1
208000008589 Obesity Diseases 0.000 description 1
240000007594 Oryza sativa Species 0.000 description 1
235000007164 Oryza sativa Nutrition 0.000 description 1
108010084695 Pea Proteins Proteins 0.000 description 1
206010036590 Premature baby Diseases 0.000 description 1
241000588769 Proteus <enterobacteria> Species 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
235000002595 Solanum tuberosum Nutrition 0.000 description 1
244000061456 Solanum tuberosum Species 0.000 description 1
108010073771 Soybean Proteins Proteins 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
244000098338 Triticum aestivum Species 0.000 description 1
241000700605 Viruses Species 0.000 description 1
108010046377 Whey Proteins Proteins 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
230000001195 anabolic effect Effects 0.000 description 1
235000021120 animal protein Nutrition 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
235000021342 arachidonic acid Nutrition 0.000 description 1
229940114079 arachidonic acid Drugs 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000007375 bacterial translocation Effects 0.000 description 1
210000004082 barrier epithelial cell Anatomy 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
235000019425 dextrin Nutrition 0.000 description 1
102000038379 digestive enzymes Human genes 0.000 description 1
108091007734 digestive enzymes Proteins 0.000 description 1
239000001177 diphosphate Substances 0.000 description 1
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
235000011180 diphosphates Nutrition 0.000 description 1
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
230000004890 epithelial barrier function Effects 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
235000021323 fish oil Nutrition 0.000 description 1
235000020932 food allergy Nutrition 0.000 description 1
235000013350 formula milk Nutrition 0.000 description 1
150000002243 furanoses Chemical class 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
150000002402 hexoses Chemical class 0.000 description 1
235000020256 human milk Nutrition 0.000 description 1
210000004251 human milk Anatomy 0.000 description 1
235000021244 human milk protein Nutrition 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
208000026278 immune system disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000004673 intestinal mucosal barrier function Effects 0.000 description 1
244000000074 intestinal pathogen Species 0.000 description 1
230000003870 intestinal permeability Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
235000020778 linoleic acid Nutrition 0.000 description 1
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
239000007788 liquid Substances 0.000 description 1
235000021239 milk protein Nutrition 0.000 description 1
150000004712 monophosphates Chemical class 0.000 description 1
210000004877 mucosa Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
235000008935 nutritious Nutrition 0.000 description 1
235000020824 obesity Nutrition 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
244000052769 pathogen Species 0.000 description 1
235000019702 pea protein Nutrition 0.000 description 1
230000035515 penetration Effects 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000000770 proinflammatory effect Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
150000003214 pyranose derivatives Chemical class 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000005070 sampling Methods 0.000 description 1
210000002151 serous membrane Anatomy 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
229940001941 soy protein Drugs 0.000 description 1
230000037351 starvation Effects 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
229940034208 thyroxine Drugs 0.000 description 1
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000005945 translocation Effects 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
230000003313 weakening effect Effects 0.000 description 1
235000021119 whey protein Nutrition 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Nutrition Science (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pediatric Medicine (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

RU2010115277/13A 2007-09-17 2008-09-17 Высококалорийные питательные композиции RU2486772C2 (ru)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
NLPCT/NL2007/000230		2007-09-17
NL2007000230		2007-09-17
PCT/NL2008/050607 WO2009038458A1 (fr)	2007-09-17	2008-09-17	Formulation nutritionnelle riches en énergie

Publications (2)

Publication Number	Publication Date
RU2010115277A RU2010115277A (ru)	2011-10-27
RU2486772C2 true RU2486772C2 (ru)	2013-07-10

Family

ID=39666199

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RU2010115277/13A RU2486772C2 (ru)	2007-09-17	2008-09-17	Высококалорийные питательные композиции

Country Status (13)

Country	Link
US (1)	US20100261642A1 (fr)
EP (3)	EP2428125B1 (fr)
CN (2)	CN104585749B (fr)
AT (1)	ATE536105T1 (fr)
BR (1)	BRPI0816993A2 (fr)
DK (1)	DK2190304T3 (fr)
ES (1)	ES2377565T3 (fr)
MX (1)	MX2010002978A (fr)
PL (1)	PL2190304T3 (fr)
PT (1)	PT2190304E (fr)
RU (1)	RU2486772C2 (fr)
SI (1)	SI2190304T1 (fr)
WO (1)	WO2009038458A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2010134800A1 (fr) *	2009-05-19	2010-11-25	N.V. Nutricia	Agent d'enrichissement du lait destiné à la consommation humaine à forte teneur en protéines et en acides gras polyinsaturés à longue chaîne, destiné à améliorer la répartition du tissu adipeux dans l'organisme
CA2771283A1 (fr) *	2009-08-13	2011-02-17	Nestec S.A.	Compositions nutritionnelles comprenant des nucleotides exogenes
ES2569922T3 (es) *	2009-11-25	2016-05-13	Nestec S.A.	Composiciones nutritivas, que incluyen un componente de alto contenido en proteínas y nucleótidos exógenos
WO2011139621A1 (fr) *	2010-04-26	2011-11-10	Nestec S.A.	Compositions nutritives, et procédé pour sevrer de l'alimentation parentérale en vue du passage à l'alimentation par voie intestinale
EP2404507A1 (fr) *	2010-07-08	2012-01-11	Nestec S.A.	Gamme de laits artificiels adaptés à l'âge avec une teneur optimale en matières grasses
US20130064923A1 (en) *	2011-09-13	2013-03-14	Agropur Cooperative	Liquid Milk Beverage For Toddlers
WO2014171813A1 (fr) *	2013-04-17	2014-10-23	N.V. Nutricia	Composition nutritionnelle pour améliorer la fonction du cerveau dans la phénylcétonurie
CN109562117A (zh) *	2016-08-04	2019-04-02	雀巢产品技术援助有限公司	具有2FL和LNnT的营养组合物，用于通过作用于肠道微生物群生态失调来预防和/或治疗非轮状病毒腹泻

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2243698C2 (ru) *	1999-12-13	2005-01-10	Н.В. Нютрисиа	Композиция для детского питания (варианты) и способ получения белкового гидролизата
WO2005122790A1 (fr) *	2004-06-22	2005-12-29	N.V. Nutricia	Amelioration de l'integrite de la barriere intestinale
WO2006091103A2 (fr) *	2005-02-28	2006-08-31	N.V. Nutricia	Composition nutritive contenant des probiotiques
WO2007046699A2 (fr) *	2005-10-21	2007-04-26	N.V. Nutricia	Methode pour stimuler l'integrite de la barriere intestinale apres une naissance non naturelle
WO2007073193A2 (fr) *	2005-12-23	2007-06-28	N.V. Nutricia	Compositions nutritionnelles destinees a prevenir l'obesite

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5472952A (en)	1993-03-18	1995-12-05	Bristol-Myers Squibb Company	Partially hydrolyzed pectin in nutritional compositions
US5438042B1 (en) *	1993-10-08	1997-08-26	Sandoz Nutrition Ltd	Enteral nutritional composition having amino acid profile
DE10057290B4 (de) *	2000-11-17	2004-01-08	Fresenius Kabi Deutschland Gmbh	Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
SG165994A1 (en) *	2002-10-10	2010-11-29	Wyeth Corp	Infant formula containing nucleotides
US7867541B2 (en) *	2003-04-14	2011-01-11	Mead Johnson Nutrition Company	Compositions and methods of formulation for enteral formulas containing sialic acid
EP1634599A1 (fr) *	2004-08-20	2006-03-15	N.V. Nutricia	Aliment infantile à activité immunostimulatrice
PT1940248E (pt)	2005-10-05	2010-01-26	Nestec Sa	Utilização de uma composição nutricional para promoção do crescimento acelerado
DK1800675T3 (da) *	2005-12-23	2011-09-05	Nutricia Nv	Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
PL1981358T3 (pl) *	2006-01-31	2011-04-29	Nestec Sa	Kompozycja żywieniowa dla noworodków z niską wagą urodzeniową
US20080003330A1 (en) *	2006-06-30	2008-01-03	Ricardo Rueda	Infant formulas for early brain development
US20080089981A1 (en) *	2006-10-17	2008-04-17	N.V. Nutricia	Ketogenic diet

2008
- 2008-09-17 WO PCT/NL2008/050607 patent/WO2009038458A1/fr not_active Ceased
- 2008-09-17 PT PT08831921T patent/PT2190304E/pt unknown
- 2008-09-17 SI SI200830553T patent/SI2190304T1/sl unknown
- 2008-09-17 BR BRPI0816993-4A2A patent/BRPI0816993A2/pt not_active Application Discontinuation
- 2008-09-17 DK DK08831921.5T patent/DK2190304T3/da active
- 2008-09-17 EP EP11192130.0A patent/EP2428125B1/fr active Active
- 2008-09-17 AT AT08831921T patent/ATE536105T1/de active
- 2008-09-17 US US12/678,243 patent/US20100261642A1/en not_active Abandoned
- 2008-09-17 RU RU2010115277/13A patent/RU2486772C2/ru active
- 2008-09-17 CN CN201410818358.5A patent/CN104585749B/zh active Active
- 2008-09-17 PL PL08831921T patent/PL2190304T3/pl unknown
- 2008-09-17 MX MX2010002978A patent/MX2010002978A/es active IP Right Grant
- 2008-09-17 EP EP08831921A patent/EP2190304B1/fr not_active Revoked
- 2008-09-17 CN CN200880116495.7A patent/CN101888793B/zh active Active
- 2008-09-17 ES ES08831921T patent/ES2377565T3/es active Active
- 2008-09-17 EP EP17171310.0A patent/EP3263120A1/fr not_active Withdrawn

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2243698C2 (ru) *	1999-12-13	2005-01-10	Н.В. Нютрисиа	Композиция для детского питания (варианты) и способ получения белкового гидролизата
WO2005122790A1 (fr) *	2004-06-22	2005-12-29	N.V. Nutricia	Amelioration de l'integrite de la barriere intestinale
WO2006091103A2 (fr) *	2005-02-28	2006-08-31	N.V. Nutricia	Composition nutritive contenant des probiotiques
WO2007046699A2 (fr) *	2005-10-21	2007-04-26	N.V. Nutricia	Methode pour stimuler l'integrite de la barriere intestinale apres une naissance non naturelle
WO2007073193A2 (fr) *	2005-12-23	2007-06-28	N.V. Nutricia	Compositions nutritionnelles destinees a prevenir l'obesite

Also Published As

Publication number	Publication date
CN104585749A (zh)	2015-05-06
WO2009038458A1 (fr)	2009-03-26
PL2190304T3 (pl)	2012-04-30
EP3263120A1 (fr)	2018-01-03
ES2377565T3 (es)	2012-03-28
EP2428125B1 (fr)	2017-05-17
SI2190304T1 (sl)	2012-04-30
RU2010115277A (ru)	2011-10-27
CN101888793B (zh)	2015-01-14
ATE536105T1 (de)	2011-12-15
MX2010002978A (es)	2010-06-09
US20100261642A1 (en)	2010-10-14
EP2190304A1 (fr)	2010-06-02
CN101888793A (zh)	2010-11-17
EP2428125A2 (fr)	2012-03-14
DK2190304T3 (da)	2012-03-12
BRPI0816993A2 (pt)	2014-10-07
EP2428125A3 (fr)	2014-08-27
CN104585749B (zh)	2018-12-28
PT2190304E (pt)	2012-03-20
EP2190304B1 (fr)	2011-12-07

Publication	Publication Date	Title
US11135290B2 (en)	2021-10-05	Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
RU2444911C2 (ru)	2012-03-20	Смесь для кормления недоношенных детей
RU2486772C2 (ru)	2013-07-10	Высококалорийные питательные композиции
RU2501553C2 (ru)	2013-12-20	Питательная композиция, способствующая здоровому развитию и росту
RU2475051C2 (ru)	2013-02-20	Детское питание с нежизнеспособными бифидобактериями и неусвояемыми олигосахаридами
ES2667393T3 (es)	2018-05-10	Oligosacáridos de leche humana para modular inflamación
ES2666491T5 (en)	2025-10-27	Composition for use in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
US11446316B2 (en)	2022-09-20	Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN113662199A (zh)	2021-11-19	用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
PT1940247E (pt)	2009-09-09	Método para estimular a integridade da barreira intestinal depois de um nascimento não natural
SG191394A1 (en)	2013-08-30	Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
WO2020013683A1 (fr)	2020-01-16	Composition nutritionnelle pour améliorer l'intégrité de la barrière intestinale, préparation de la composition et procédé de traitement
WO2022226311A1 (fr)	2022-10-27	Compositions nutritionnelles comprenant des oligosaccharides de lait humain et un constituant lipidique désigné d'amélioration de fonction pulmonaire
RU2716214C2 (ru)	2020-03-06	Композиция для улучшения умственных способностей
WO2024231340A1 (fr)	2024-11-14	Composition nutritionnelle avec du galactose pour nourrissons ou jeunes enfants
WO2025233455A1 (fr)	2025-11-13	Composition nutritionnelle pour renforcer la barrière intestinale
HK40039062A (en)	2021-07-09	Human milk oligosaccharides for modulating inflammation